Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/25/15 → 6/25/18 |
Funding
- Regeneron Pharmaceuticals, Inc. (Prot #R668-EE-1324)
Prot #R668-EE-1324: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis
- Hirano, Ikuo (PD/PI)
Project: Research project